Komori
Alfresa Holdings (2784) · FactFirst stated

Revenue and profit growth in the FY2024-Q1 self-medication wholesale business

First written in FY2024-Q1. . Latest entry: FY2024-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Recovery in Self-Medication Wholesale Demand Driven by Returning Foot Traffic and Inbound DemandA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1First statedAnnual report

    「当セグメントの当第１四半期連結累計期間の業績は、新型コロナウイルス感染症の「５類」移行後の都市部における人流回復に加えて、訪日外国人増加によるインバウンド需要増に伴う市場回復の影響から増収となったこと等により、売上高646億27百万円(前年同期比8.4％増)、営業利益7億70百万円(同71.9％増)となりました。」

    セルフメディケーション卸売事業は、人流回復とインバウンド需要増に伴う市場回復により増収増益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.